These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 23909921)

  • 1. Meta-analysis of the association of dermatomyositis and polymyositis with cancer.
    Wang J; Guo G; Chen G; Wu B; Lu L; Bao L
    Br J Dermatol; 2013 Oct; 169(4):838-47. PubMed ID: 23909921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic inflammatory myopathy associated with malignancy: a retrospective cohort of 151 Korean patients with dermatomyositis and polymyositis.
    So MW; Koo BS; Kim YG; Lee CK; Yoo B
    J Rheumatol; 2011 Nov; 38(11):2432-5. PubMed ID: 21844145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The overall and temporal association of cancer with polymyositis and dermatomyositis.
    Zantos D; Zhang Y; Felson D
    J Rheumatol; 1994 Oct; 21(10):1855-9. PubMed ID: 7837150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis or dermatomyositis: a retrospective study.
    Ji SY; Zeng FQ; Guo Q; Tan GZ; Tang HF; Luo YJ; Tang ZQ; Han YF
    Chin Med J (Engl); 2010 Mar; 123(5):517-22. PubMed ID: 20367973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors Associated with Interstitial Lung Disease in Patients with Polymyositis and Dermatomyositis: A Systematic Review and Meta-Analysis.
    Zhang L; Wu G; Gao D; Liu G; Pan L; Ni L; Li Z; Wang Q
    PLoS One; 2016; 11(5):e0155381. PubMed ID: 27171228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymyositis/dermatomyositis and malignancy risk: a metaanalysis study.
    Yang Z; Lin F; Qin B; Liang Y; Zhong R
    J Rheumatol; 2015 Feb; 42(2):282-91. PubMed ID: 25448790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk factors associated with cardiac involvement in patients with dermatomyositis/polymyositis].
    Zuo C; Wei XD; Ye YL; Liang Y; Yin G; Yang M; Xie QB
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):801-4, 809. PubMed ID: 24325116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical analysis of pneumomediastinum complicated in polymyositis and dermatomyositis].
    Tong SQ; Shi XH; Su JM; Zhao Y; Zhang FC
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):624-7. PubMed ID: 16681909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis/dermatomyositis].
    Wang PZ; Guan JL; Han XH
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jun; 31(6):417-20. PubMed ID: 19031800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study.
    Stockton D; Doherty VR; Brewster DH
    Br J Cancer; 2001 Jul; 85(1):41-5. PubMed ID: 11437400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of the clinical picture and serologic profile in patients with dermatomyositis and polymyositis coexisting with neoplastic disease].
    Bobrowska-Snarska D; Ostanek L; Brzosko M
    Ann Acad Med Stetin; 2011; 57(2):32-8. PubMed ID: 23002666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated cancer incidence in patients with dermatomyositis: a population based study.
    Airio A; Pukkala E; Isomäki H
    J Rheumatol; 1995 Jul; 22(7):1300-3. PubMed ID: 7562762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignancies associated with dermatomyositis and polymyositis in Taiwan: a nationwide population-based study.
    Huang YL; Chen YJ; Lin MW; Wu CY; Liu PC; Chen TJ; Chen YC; Jih JS; Chen CC; Lee DD; Chang YT; Wang WJ; Liu HN
    Br J Dermatol; 2009 Oct; 161(4):854-60. PubMed ID: 19558555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematological malignancy associated with polymyositis and dermatomyositis.
    Marie I; Guillevin L; Menard JF; Hatron PY; Cherin P; Amoura Z; Cacoub P; Bachelez H; Buzyn A; Le Roux G; Ziza JM; Brice P; Munck JN; Sarrot-Reynauld F; Piette JC; Larroche C
    Autoimmun Rev; 2012 Jul; 11(9):615-20. PubMed ID: 22079677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surfactant proteins-A and D as important serum markers for interstitial lung disease in patients with polymyositis or dermatomyositis].
    Chen F; Shu XM; Wang DX; Xie Y; Wang GC
    Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(31):2182-5. PubMed ID: 23158422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study.
    Chen YJ; Wu CY; Shen JL
    Br J Dermatol; 2001 Apr; 144(4):825-31. PubMed ID: 11298544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients.
    Marie I; Hatron PY; Dominique S; Cherin P; Mouthon L; Menard JF
    Arthritis Rheum; 2011 Nov; 63(11):3439-47. PubMed ID: 21702020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors predicting malignancy in patients with polymyositis and dermatomyostis: a systematic review and meta-analysis.
    Lu X; Yang H; Shu X; Chen F; Zhang Y; Zhang S; Peng Q; Tian X; Wang G
    PLoS One; 2014; 9(4):e94128. PubMed ID: 24713868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between the onset and outcome of interstitial pneumonia associated with polymyositis and dermatomyositis].
    Saku N; Ohno S; Sugiyama Y; Kitamura S
    Nihon Kokyuki Gakkai Zasshi; 1998 Jul; 36(7):585-9. PubMed ID: 9805908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk of venous thromboembolism in patients with dermatomyositis/polymyositis: a nationwide cohort study.
    Chung WS; Lin CL; Sung FC; Lu CC; Kao CH
    Thromb Res; 2014 Sep; 134(3):622-6. PubMed ID: 25034321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.